Circadian Rhythm
0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
2 programsCircadian Based Time Restricted EatingN/A1 trial
Sleep Regularity GroupN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
ResMedCircadian monitoring device
Oregon TherapeuticsSleep Regularity Group
Oregon TherapeuticsCircadian Based Time Restricted Eating
Clinical Trials (3)
Total enrollment: 70 patients across 3 trials
Circadian Rhythm Monitoring Study
Start: Feb 2026Est. completion: Jun 202630 patients
N/ANot Yet Recruiting
The Influence of Sleep on Cardiovascular Outcomes
Start: Jul 2024Est. completion: Sep 202630 patients
N/ARecruiting
Circadian Time Restricted Eating
Start: Apr 2023Est. completion: Dec 202410 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 70 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.